ArticleCancer science2026
MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular Toxicity.
Shigeki Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancer science2026
Shigeki Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.